Definitive Contract 75N95018C00012
Award Date
4/12/18
Potential Completion Date
5/31/20
Potential Value
$1.5M
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Cairn Biosciences Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Cairn Biosciences Inc., a woman-owned small business. The contract, valued at $230,000.00, is for the development of a "Multifunctional, Reusable and Automated Microfluidic Smart Plate for High Throughput Live Cell Assays". The contract has a Firm Fixed Price pricing type and a period of performance ending on February...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a Small Business Innovation Research (SBIR) Phase I contract to Cairn Biosciences Inc., a woman-owned small business, for the development of a microfluidic and machine learning-enabled smart laboratory system for autonomous remote execution and iteration of multiscale live cell assays for drug discovery. The firm-fixed-price contract has a potential value of...
<p>This is a $229,893.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Cairn Biosciences Inc., a woman-owned small business. The contract is for the development of a "MULTIPLEXED HIGH CONTENT ASSAY FOR TOXICITY MECHANISMS AND PHENOTYPES IN LIVE IPSC-DERIVED CARDIAC CELLS." The contract is a definitive, firm-fixed price contract with a completion date of May 14, 2017.</p>
This is a $1,499,999.00 Firm Fixed Price contract awarded by the National Institute on Drug Abuse, a civilian agency, to Cairn Biosciences Inc., a woman-owned small business, for the development of a Multiplexed High-Content Assay to Measure Cellular Stress Mechanisms for Predictive Toxicology Studies. The contract was awarded under the SBIR Program Phase II and has a total small business set-aside designation. The contract was awarded on September 13, 2016 with an ultimate completion date of...
<p>The National Center for Advancing Translational Sciences, a civilian agency, awarded a Firm Fixed Price definitive contract worth $225,000.00 to Cairn Biosciences Inc., a Woman Owned Small Business, for the development of a "MULTIPLEXED HIGH CONTENT ASSAY TO MEASURE ENDOPLASMIC RETICULUM STRESS FOR PREDICTIVE TOXICOLOGY". The contract has a total small business set-aside and is scheduled for completion by March 14, 2016.</p>
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to CFD Research Corporation, a small business, for the SMARTPLATE TECHNOLOGY FOR ADVANCED CELLULAR (STAC-M) research project. The $1,499,740.00 firm fixed-price contract was awarded on September 7, 2017 under the SBIR Program Phase II with a completion date of November 14, 2020. CFD Research has a history of providing research,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Micromics Technologies LLC for the development of an "Integrated Platform for In-Depth Single-Cell Proteomics". The contract has a performance period from September 13, 2021 to June 12, 2022 and a ceiling value of $455,000. It is a firm fixed-price definitive contract set aside for small businesses. The original...
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the Department of Health and Human Services. The contract, valued at $107,500.00, is for the procurement of an Incucyte S3 DH/2CLR System Package, a specialized live cell analysis instrument used in biomedical research. The contract was awarded to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB)...
This is a $1,648,645.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Cell Microsystems Inc. under the Small Business Innovation Research (SBIR) Phase II program. The purpose of this contract is to focus on developing a T-cell activation protocol consistent with reporter cell viability, creating a proprietary reporter cell line, and gathering and benchmarking...
This Small Business Innovation Research (SBIR) Phase I contract, valued at $399,674, was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Inso Biosciences Inc., a small biotechnology startup. The contract supports the research and development of advanced sample processing platforms for downstream single-cell multi-omic analysis. This work aligns with the NIH and Centers for Disease Control and Prevention (CDC) mission to develop medical...